Drug Profile
Insulin aspart biosimilar - Wockhardt
Latest Information Update: 31 Oct 2021
Price :
$50
*
At a glance
- Originator Wockhardt
- Class Antihyperglycaemics; Insulins; Pancreatic hormones; Peptides
- Mechanism of Action Ornithine decarboxylase stimulants; Phosphokinase stimulants; Protein tyrosine kinase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Diabetes mellitus
Most Recent Events
- 28 Jul 2019 No recent reports of development identified for preclinical development in Diabetes-mellitus in India
- 09 Jun 2015 Preclinical trials in Diabetes mellitus in India (unspecified route) (CTRI2015-06-005901)